学术探索
学术期刊
新闻热点
数据分析
智能评审

PHARMACOLOGY OF L-660,711 (MK-571) - A NOVEL POTENT AND SELECTIVE LEUKOTRIENE-D4 RECEPTOR ANTAGONIST

被引：297
作者：
JONES, TR
ZAMBONI, R
BELLEY, M
CHAMPION, E
CHARETTE, L
FORDHUTCHINSON, AW
FRENETTE, R
GAUTHIER, JY
LEGER, S
MASSON, P
MCFARLANE, CS
PIECHUTA, H
ROKACH, J
WILLIAMS, H
YOUNG, RN
DEHAVEN, RN
PONG, SS
机构：
[1] MERCK FROSST CANADA INC,DEPT MED CHEM,DORVAL H9R 4P8,QUEBEC,CANADA
[2] MERCK SHARP & DOHME RES LABS,DEPT BIOCHEM INFLAMMAT,RAHWAY,NJ 07065
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 1989年 / 67卷 / 01期
关键词：
D O I：
10.1139/y89-004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：17 / 28
页数：12
相关论文
共 51 条
  • [1] PRODUCTION OF EARLY AND LATE PULMONARY RESPONSES WITH INHALED LEUKOTRIENE-D4 IN ALLERGIC SHEEP
    ABRAHAM, WM
    RUSSI, E
    WANNER, A
    DELEHUNT, JC
    YERGER, LD
    CHAPMAN, GA
    [J]. PROSTAGLANDINS, 1985, 29 (05): : 715 - 726
  • [2] ABRAHAM WM, 1988, FASEB J, V2, P4425
  • [3] AHARONY D, 1987, J PHARMACOL EXP THER, V243, P921
  • [4] APPELGREN LE, 1982, J BIOL CHEM, V257, P531
  • [5] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [6] SELECTIVE INHIBITOR OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS
    AUGSTEIN, J
    FARMER, JB
    LEE, TB
    SHEARD, P
    TATTERSALL, ML
    [J]. NATURE-NEW BIOLOGY, 1973, 245 (146): : 215 - 217
  • [7] Barnes N, 1988, Prog Clin Biol Res, V263, P393
  • [8] THE EFFECT OF AN ORAL LEUKOTRIENE ANTAGONIST L-649,923 ON HISTAMINE AND LEUKOTRIENE-D4-INDUCED BRONCHOCONSTRICTION IN NORMAL MAN
    BARNES, N
    PIPER, PJ
    COSTELLO, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (05) : 816 - 821
  • [9] COMPARATIVE EFFECTS OF INHALED LEUKOTRIENE-C4, LEUKOTRIENE-D4, AND HISTAMINE IN NORMAL HUMAN-SUBJECTS
    BARNES, NC
    PIPER, PJ
    COSTELLO, JF
    [J]. THORAX, 1984, 39 (07) : 500 - 504
  • [10] L-656,224 (7-CHLORO-2-[(4-METHOXYPHENYL)METHYL]-3-METHYL-5-PROPYL-4-BENZOFURANOL) - A NOVEL, SELECTIVE, ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR
    BELANGER, P
    MAYCOCK, A
    GUINDON, Y
    BACH, T
    DOLLOB, AL
    DUFRESNE, C
    FORDHUTCHINSON, AW
    GALE, PH
    HOPPLE, S
    LAU, CK
    LETTS, LG
    LUELL, S
    MCFARLANE, CS
    MACINTYRE, E
    MEURER, R
    MILLER, DK
    PIECHUTA, H
    RIENDEAU, D
    ROKACH, J
    ROUZER, C
    SCHEIGETZ, J
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1987, 65 (12) : 2441 - 2448
123456